More

    Mylan

    Mylan, Inc. history, company profile (overview) and corporate video

       Mylan, Inc. was a generic and specialty pharmaceutical company headquartered in Canonsburg, Pennsylvania, United States.

    HISTORY


       Mylan was founded in 1961 as Milan Pharmaceuticals by Milan Puskar and Don Panoz in White Sulphur Springs, West Virginia, to ensure access to affordable medicine in difficult-to-reach communities.

       In 1973, Mylan became a publicly traded company on the OTC market under the MYLN symbol, and in 1976 moved to NASDAQ.

       In 1993, Mylan acquired Bertek Inc.

       In 1999, the company was renamed Mylan Technologies Inc.

       In 1996, Mylan acquired UDL Laboratories, a supplier of generic medications to institutional and long-term care facilities.

       In 2007, Mylan Laboratories Inc. changed its name to Mylan Inc.

       In 2007, Mylan also acquired the generics arm of Merck KGaA.

       In 2011, Mylan entered into an agreement with Pfizer for the exclusive worldwide rights to develop, manufacture and commercialize Pfizer’s generic equivalent to GlaxoSmithKline‘s Advair® Diskus and Seretide® Diskus incorporating Pfizer’s proprietary dry powder inhaler delivery platform.

       In 2020, Mylan merged with Upjohn (a legacy division of Pfizer) and formed Viatris.

    - Advertisement -

    *Information from Forbes.com, Wikipedia.org, and www.viatris.com/en.

    **Video published on YouTube by “mylanlabs“.

    Advertisment

    Advertisment

    Related videos

    Advertisment

    Advertisment